APhA Delegates Materials for 2014 provide retaining the following policy statement regarding compounding with multicomponent vehicles

PHARMACY PRACTICE

15. The Committee recommends RETAINING the following policy statement as written.

2005 Compounding with Multicomponent Vehicles

 

 

 

1. APhA encourages companies that offer multi-component vehicles for compounding to list all

ingredients and to restrict claims about the vehicles to the structure and function of the ingredients in

those vehicles unless clinical evidence exists to support more specific claims.

2. When claims are made by companies for systemic delivery of active ingredients in multicomponent

vehicles, APhA encourages pharmacists to secure bioavailability data in support of such

claims.

(JAPhA NS45(5):555 September/October 2005)(Reviewed 2009)

SOURCE FOUND HERE